|
group
|
n
|
α-SMA
|
Alb
|
CK 7
|
TGFβ1
|
|---|
|
sham control group
|
8
|
0.02 ± 0.01##
|
0.53 ± 0.03##
|
0.00 ± 0.00##
|
0.03 ± 0.01##
|
|
1 week BDL alone group
|
8
|
0.03 ± 0.01##
|
0.34 ± 0.02**##
|
0.06 ± 0.02**##
|
0.07 ± 0.02*##
|
|
2 week BDL alone group
|
8
|
0.06 ± 0.01**##
|
0.30 ± 0.02**##
|
0.10 ± 0.02**##
|
0.11 ± 0.03**##
|
|
3 week BDL alone group
|
8
|
0.14 ± 0.02**##
|
0.24 ± 0.02**##
|
0.16 ± 0.02**##
|
0.15 ± 0.03**##
|
|
4 week BDL alone group
|
8
|
0.27 ± 0.03**##
|
0.19 ± 0.02**##
|
0.19 ± 0.01**
|
0.17 ± 0.02**
|
|
5 week BDL alone group
|
10
|
0.36 ± 0.03**
|
0.14 ± 0.02**
|
0.21 ± 0.02**
|
0.20 ± 0.02**
|
|
IHQD group
|
14
|
0.11 ± 0.02**##
|
0.28 ± 0.01**##
|
0.15 ± 0.02**##
|
0.15 ± 0.03**##
|
- Note: Compared with sham control group, *p < 0.05, **p < 0.01; compared with 5 week BDL alone group, #p < 0.05, ##p < 0.01. α-SMA α-smooth muscle actin, Alb albumin, CK 7 cytokeratin 7, TGFβ1 transforming growth factor β1
